Traders should monitor for any immediate prospectus supplements or 8-K filings indicating actual offerings; the shelf capacity provides funding flexibility but creates overhang risk. Given the OTC listing and multiple concurrent shelf effectiveness notices, assess whether this reflects upcoming financing plans or administrative cleanup.
Price Chart
Executive Summary
COSCIENS Biopharma Inc. (formerly Aeterna Zentaris Inc.) has had five separate registration statements (Form S-3) become effective simultaneously on March 18, 2026, covering shelf offerings of up to $75 million in aggregate. The filings suggest the company now has broad flexibility to raise capital through various securities offerings over time.
Key Facts
- Five Form EFFECT filings accepted on March 19, 2026, with effectiveness dated March 18, 2026
- Each relates to a previously filed Form S-3 registration (file numbers: 333-239019, 333-239264, 333-248561, 333-254680, 333-277115)
- Total aggregate offering capacity across all shelf registrations is $75 million
- Company is on OTC market and formerly known as Aeterna Zentaris Inc.
- No immediate securities sale is indicated — this is a qualification to sell in the future
Financial Impact
Up to $75 million in potential future dilution or debt issuance under shelf registrations
Risk Factors
- Potential for near-term dilutive equity offerings
- Execution risk if capital is raised in a down market
- OTC listing may limit investor appetite despite shelf availability
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 15 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (CSCIF) — Batch item 1 | 9999999995-26-000852 |
| Document: 9999999995-26-000852-index.html | 9999999995-26-000847 |
| Document: 9999999995-26-000852.txt | 9999999995-26-000845 |
| EFFECT Filing (CSCIF) — Batch item 4 | 9999999995-26-000847 |
| Document: 9999999995-26-000847-index.html | 9999999995-26-000843 |
| Document: 9999999995-26-000847.txt | 9999999995-26-000852 |
| EFFECT Filing (CSCIF) — Batch item 7 | 9999999995-26-000845 |
| Document: 9999999995-26-000845-index.html | 9999999995-26-000852 |
| Document: 9999999995-26-000845.txt | 9999999995-26-000852 |
| EFFECT Filing (CSCIF) — Batch item 10 | 9999999995-26-000844 |
| Document: 9999999995-26-000844-index.html | 9999999995-26-000852 |
| Document: 9999999995-26-000844.txt | 9999999995-26-000852 |
| EFFECT Filing (CSCIF) — Batch item 13 | 9999999995-26-000843 |
| Document: 9999999995-26-000843-index.html | 9999999995-26-000852 |
| Document: 9999999995-26-000843.txt | 9999999995-26-000852 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 6, 2026 16w ago | 6-K | $7.05 $5.14 | ▲ +27.09% | ▲ +27.94% | $6.10 (+13.48%) |
Jun 18, 2026 18w ago | 6-K | $2.26 $5.75 | ▲ +154.42% | ▲ +154.89% | $6.10 (+169.91%) |
May 12, 2026 24w ago | 6-K | $1.93 $2.03 | ▲ +5.18% | ▲ +5.79% | $6.10 (+216.06%) |
May 8, 2026 24w ago | 6-K | $1.91 $1.97 | ▲ +3.14% | ▲ +3.45% | $6.10 (+219.37%) |
Apr 20, 2026 27w ago | 6-K | $2.03 $1.87 | ▼ −7.88% | ▼ −12.08% | $6.10 (+200.49%) |
Mar 19, 2026 31w ago | EFFECT | $0.8600 $2.03 | ▲ +136.05% | ▲ +128.43% | $6.10 (+609.30%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers